NCT03428594View on ClinicalTrials.gov

CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Anemia of Chronic Kidney Disease
Interventions
BIOLOGICAL

CKD-11101

BIOLOGICAL

NESP

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03428594 - CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis | Biotech Hunter | Biotech Hunter